Search results

Order by most recent / most popular / relevance

Results: 1-10 of 6,785

Update in the US Supreme Court landmark myriad gene patent case

Shelston IP
-
USA
-
June 11 2013

A decision is expected later this month from the U.S. Supreme Court in the case of Association for Molecular Pathology v. Myriad Genetics Inc., which

US and European approaches to antibody patents

FB Rice
-
European Union, USA
-
June 13 2013

When monoclonal antibodies were first produced in 1974, Kohler and Milstein predicted that they “could be valuable for medical and industrial use”

Supreme Court decision in association for Molecular Pathology v. Myriad Genetics, Inc.

Fish & Richardson PC
-
USA
-
June 13 2013

In a much-anticipated decision, the Supreme Court today issued its opinion in Association for Molecular Pathology v. Myriad Genetics, Inc. Justice

Remembering what’s not written: implied terms

Mills & Reeve LLP
-
United Kingdom
-
June 6 2013

When interpreting a contract, it's not just the express terms of the contract that are important. Careful consideration should also be given to

Supreme Court amends earlier decision: Viagra patent not void

Bereskin & Parr LLP
-
Canada
-
June 6 2013

In Teva Canada Ltd v Pfizer Canada Inc, the Supreme Court of Canada (the "SCC") held Pfizer's Canadian Patent No. 2,163,446 (the '446 Patent) to be

TPPs not allowed to throw own insureds under the bus

Reed Smith LLP
-
USA
-
June 6 2013

Third party payer plaintiffs (mostly insurance companies and union welfare funds in unholy alliance with plaintiff lawyers), have not been doing very

New mental health safety standard may impact employers’ duties related to employee mental health

Borden Ladner Gervais LLP
-
Canada
-
June 4 2013

Recent studies have shown that one in five Canadians will experience a mental illness in their lifetime, and that mental health is the number one

After reconsideration, the Viagra patent is not void

Fasken Martineau DuMoulin LLP
-
Canada
-
June 11 2013

Close to seven months after rendering its decision in Teva Canada Ltd v Pfizer Canada Inc., 2012 SCC 60, the Supreme Court of Canada varied its

Delaware Supreme Court: bad-faith attempt to renegotiate term sheet may create liability for “benefit-of-the-bargain” damages

Morrison & Foerster LLP
-
USA
-
June 10 2013

A term sheet can play a useful role by allowing the parties to focus on key issues first, without getting bogged down in details. But what happens

Pharmaceutical trade marks case law round up for 2012early 2013

Corrs Chambers Westgarth
-
Australia, European Union, USA
-
June 6 2013

A brief wrap-up of recent decisions relating to trade marks in the pharma space from the EU, the United States and Australia

next >

Search results

Update in the US Supreme Court landmark myriad gene patent case

US and European approaches to antibody patents

Supreme Court decision in association for Molecular Pathology v. Myriad Genetics, Inc.

Remembering what’s not written: implied terms

Supreme Court amends earlier decision: Viagra patent not void

TPPs not allowed to throw own insureds under the bus

New mental health safety standard may impact employers’ duties related to employee mental health

After reconsideration, the Viagra patent is not void

Delaware Supreme Court: bad-faith attempt to renegotiate term sheet may create liability for “benefit-of-the-bargain” damages

Pharmaceutical trade marks case law round up for 2012early 2013

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea